Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109953 · ClinicalTrials.gov registry record
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 6
- Enrollment target
NCT01109953: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01109953 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01109953 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The patient has been referred for an FDG PET/CT scan. FDG is a form of sugar that contains a small amount of radioactivity; it is used to see the size and possible spread of cancer in the body. Pictures of the body are taken on a machine called a PET/CT scanner. The purpose of this current study is to see if we, the investigators, can take clearer pictures of the tumor than we could with our routine scan method. This would allow us to better see how FDG is picked up by the tumor. PET/CT is presently one of the best tools for detecting cancer and determining its spread in the body. However, due to breathing motion, PET and CT images may become blurred and the location of the tumor on CT and PET images may not match. We have developed a new method that enables us to reduce image blurring and to measure the tumor more accurately on PET images. In this study we want to compare two kinds of images: those from the standard PET/CT scan, and the PET/CT scan pictures taken with our new method. If successful, we may use this new method for clinical routine in the future.
Interventions
- OTHER Breath-Hold PET/CT image set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01109953
The ClinicalTrials.gov registry entry for NCT01109953 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breath-Hold PET/CT image set is the first listed.
NCT01109953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01109953 about?
NCT01109953 is a clinical study titled "Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images". The patient has been referred for an FDG PET/CT scan. FDG is a form of sugar that contains a small amount of radioactivity; it is used to see the size and possible spread of cancer in the body. Pictures of the body are taken on a machine called a PET/CT scanner. The purpose of this current study is...
What is the current status of trial NCT01109953?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2010-04. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01109953?
The interventions under investigation include: Breath-Hold PET/CT image set (OTHER).
Who is sponsoring clinical trial NCT01109953?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.